MSMEI_3879Mycolicibacterium smegmatis ClpC1

Emmanuel C Ogbonna1, Henry R Anderson2, Patrick C Beardslee2

  • 1Department of Biological Sciences, University of Delaware, Newark, Delaware, USA.

Microbiology spectrum
|June 21, 2023
PubMed
概括

研究人员确定了与ClpC1相互作用的蛋白质,这是耐药结核病的潜在药物标. 这项研究揭示了一种新的基质,有助于开发针对Mycobacterium tuberculosis的新型抗生素.